Tirzepatide
Dual GIP / GLP-1 receptor agonist reference compound for incretin co-agonism research.
Unit Price
$110.00
- Latest Lot
- RQ-TIR-2406
- Availability
- In stock
Technical Specifications
Storage & Handling
Store lyophilized at -20°C, protected from light.
Reconstitute under sterile conditions. Aliquot after reconstitution.
Overview
Tirzepatide is a dual GIP and GLP-1 receptor agonist used as a reference compound in research on incretin co-agonism and metabolic signaling. Supplied lyophilized.
Research Context
Referenced in preclinical models exploring dual-incretin receptor pharmacology and metabolic research endpoints. For laboratory research use only.
Certificates of Analysis
RQ-TIR-2406
Janoshik Analytical · 2025-12-05 · 99.5%
All materials are sold strictly for laboratory and research use only. Not for human or veterinary consumption.
Related Compounds
Semaglutide
5 mg lyophilized vialGLP-1 receptor agonist analog used as a reference standard in incretin-pathway research.
- Formula
- C187H291N45O59
- CAS
- 910463-68-2
- Mol. Weight
- 4113.58 g/mol
- Purity
- ≥ 99%
Retatrutide
5 mg lyophilized vialTriple GIP / GLP-1 / glucagon receptor agonist reference peptide for metabolic research.
- Formula
- C221H342N46O68
- CAS
- 2381089-83-2
- Mol. Weight
- 4731.32 g/mol
- Purity
- ≥ 99%
BPC-157
10 mg lyophilized vialSynthetic pentadecapeptide widely used as a reference compound in tissue-repair research models.
- Formula
- C62H98N16O22
- CAS
- 137525-51-0
- Mol. Weight
- 1419.53 g/mol
- Purity
- ≥ 99%